Bringing extensive expertise in venture capital, the fund manager has successfully navigated the biotechnology and healthcare sectors across North America and Europe. With a track record of over 15 deals, they emphasize early-stage investments, leveraging a data-driven approach to identify high-potential companies. Notable exits include several successful IPOs, demonstrating a commitment to strategic, operator-first engagement with portfolio companies. Their focus on thematic investments positions them uniquely to capitalize on emerging trends within the industry.